- £86.39m
- £153.01m
- £166.14m
- 19
- 42
- 94
- 50
Annual income statement for RM, fiscal year end - November 30th, GBP millions except per share, conversion factor applied.
2020 November 30th | R2021 November 30th | C2022 November 30th | R2023 November 30th | 2024 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 189 | 206 | 214 | 176 | 166 |
Cost of Revenue | |||||
Gross Profit | 74.3 | 67.4 | 68.5 | 64.3 | 66.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 177 | 203 | 236 | 169 | 172 |
Operating Profit | 11.5 | 3.59 | -21.6 | 7.24 | -5.96 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.5 | 3.62 | -20.8 | 12.4 | -12.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.41 | 2.19 | -16.1 | 2.55 | -3.87 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8.41 | 4.19 | -14.5 | -29.1 | -4.74 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.41 | 4.19 | -14.5 | -29.1 | -4.74 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.101 | 0.143 | 0.175 | -0.104 | 0.145 |
Dividends per Share |